Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response
Top Cited Papers
- 23 March 2004
- journal article
- review article
- Published by Springer Science and Business Media LLC in Molecular Psychiatry
- Vol. 9 (5), 442-473
- https://doi.org/10.1038/sj.mp.4001494
Abstract
No abstract availableThis publication has 97 references indexed in Scilit:
- The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal FunctionCell, 2003
- Relationship between functional dopamine D2 and D3 receptors gene polymorphisms and neuroleptic malignant syndromeNeuropsychiatric Genetics, Part B of the American Journal of Medical Genetics (AJMG), 2002
- Association study of Angiotensin I-converting enzyme polymorphism and symptomatology and antidepressant response in major depressive disordersJournal of Neural Transmission, 2002
- Association analysis of a polymorphism in the G‐protein stimulatory α subunit in patients with major depression*American Journal of Medical Genetics, 2002
- Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patientsJournal of Neural Transmission, 2001
- Five Distinct Human Cytochromes Mediate Amitriptyline N‐Demethylation In Vitro: Dominance of CYP 2C19 and 3A4The Journal of Clinical Pharmacology, 1998
- The role of cytochrome P450 2D6 in the metabolism of moclobemideEuropean Neuropsychopharmacology, 1996
- Analysis of clozapine response and polymorphisms of the dopamine D4 receptor gene (DRD4) in schizophrenic patientsAmerican Journal of Medical Genetics, 1995
- Dopamine D4 receptor subtypes and response to clozapineThe Lancet, 1993
- Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in manLife Sciences, 1980